Key result
Each 5 mmHg increase in RVSP is linked to ~6% higher mortality in HF.
Why the study?
Does increasing severity of pulmonary hypertension predict all-cause mortality in patients with heart failure?
Cohort (n=1,612)
Does increasing severity of pulmonary hypertension predict all-cause mortality in patients with heart failure?
In patients with heart failure and left ventricular systolic dysfunction, each 5 mmHg increase in right ventricular systolic pressure is associated with a 6% increased risk of all-cause mortality.
Answers are grounded in this paper and cite their sources.
Higher RVSP associated with mortality in HF with LVSD; leaves open whether PH severity informs risk stratification or trials.
AIMS: The presence of pulmonary hypertension (PH) in left ventricular systolic dysfunction (LVSD) and symptomatic heart failure is an ominous sign. There are insufficient data regarding the risk conferred by increasing severity of PH in patients with heart failure. METHODS AND RESULTS: We performed a record linkage study in Tayside, Scotland (population ∼400,000) utilizing the Tayside echocardiogram database (>50,000 echocardiograms) maintained by the Health Informatics Centre (HIC). Data sets from the HIC include mortality data, cardiovascular medications, and other healthcare activities linked anonymously by the community health index (CHI) number. Patients were included in the analysis if they had LVSD, had a valid right ventricular systolic pressure (RVSP) measurement, and had a loop diuretic prescription (provided not more than 1 year prior to echocardiogram). A Cox proportional hazard model was used to examine the effects of RVSP on all-cause mortality. A total of 1612 patients [mean age, 75.2 ± 10.9 (SD) years; 57.4% male] met the entry criteria. Mean RVSP for the cohort was 44.9 ± 13.1 mmHg and mean follow-up was 2.8 ± 2.5 years. For each 5 mmHg stepwise increase in RVSP, after adjustment for confounding factors including the degree of LVSD and the presence of chronic obstructive pulmonary disease, the hazard ratio (HR) for all-cause mortality was 1.06 (1.03-1.08, P < 0.001). CONCLUSIONS: Pulmonary hypertension predicted all-cause mortality in a heterogeneous group of patients with heart failure. Each 5 mmHg rise in RVSP was associated with a 6% increased risk of death.
No takes yet. Share an insight, caveat, or question.
Szwejkowski et al. (2011) conducted a cohort in Heart failure with left ventricular systolic dysfunction (n=1,612). Right ventricular systolic pressure (RVSP) was evaluated on All-cause mortality (HR 1.06, 95% CI 1.03-1.08, p=< 0.001). Each 5 mmHg increase in right ventricular systolic pressure was associated with a higher risk of all-cause mortality in patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: